-
1
-
-
0032560807
-
Mortality from coronary heart disease in subjects with type 2 diabetes and in nondiabetic subjects with and without prior myocardial infarction
-
DOI 10.1056/NEJM199807233390404
-
Haffner SM, Lehto S, Ronnemaa T, et al. Mortality from coronary heart disease in subjects with type 2 diabetes and in nondiabetic subjects with and without prior myocardial infarction. N Engl J Med 1998;339:229-34 (Pubitemid 28350165)
-
(1998)
New England Journal of Medicine
, vol.339
, Issue.4
, pp. 229-234
-
-
Haffner, S.M.1
Lehto, S.2
Ronnemaa, T.3
Pyorala, K.4
Laakso, M.5
-
2
-
-
0026469096
-
Diabetic retinopathy A clinical overview
-
Davis MD. Diabetic retinopathy. A clinical overview. Diabetes Care 1992;15:1844-74
-
(1992)
Diabetes Care
, vol.15
, pp. 1844-1874
-
-
Davis, M.D.1
-
3
-
-
0033533807
-
Nephropathy in patients with type 2 diabetes mellitus
-
DOI 10.1056/NEJM199910073411506
-
Ritz E, Orth SR. Nephropathy in patients with type 2 diabetes mellitus. N Engl J Med 1999;341:1127-33 (Pubitemid 29466226)
-
(1999)
New England Journal of Medicine
, vol.341
, Issue.15
, pp. 1127-1133
-
-
Ritz, E.1
Orth, S.R.2
-
5
-
-
0028229508
-
Insulin resistance or insulin deficiency Which is the primary cause of NIDDM?
-
Taylor SI, Accili D, Imai Y. Insulin resistance or insulin deficiency. Which is the primary cause of NIDDM? Diabetes 1994;43(6):735-40
-
(1994)
Diabetes
, vol.43
, Issue.6
, pp. 735-740
-
-
Taylor, S.I.1
Accili, D.2
Imai, Y.3
-
6
-
-
9444242665
-
Five of stages of evolving β-cell dysfunction during progression to diabetes
-
DOI 10.2337/diabetes.53.suppl-3.S16
-
Weir GC, Bonner-Weir S. Five stages of evolving beta-cell dysfunction during progression to diabetes. Diabetes 2004;53:S16-21 (Pubitemid 39564517)
-
(2004)
Diabetes
, vol.53
, Issue.SUPPL. 3
-
-
Weir, G.C.1
Bonner-Weir, S.2
-
7
-
-
34247362354
-
Pancreatic islet dysfunction in type 2 diabetes: A rational target for incretin-based therapies
-
DOI 10.1185/030079906X167336
-
Meece J. Pancreatic islet dysfunction in type 2 diabetes: a rational target for incretin-based therapies. Curr Med Res Opin 2007;23(4):933-44 (Pubitemid 46631496)
-
(2007)
Current Medical Research and Opinion
, vol.23
, Issue.4
, pp. 933-944
-
-
Meece, J.1
-
8
-
-
0036318319
-
Lipotoxicity in human pancreatic islets and the protective effect of metformin
-
Lupi R, Del Guerra S, Fierabracci V, et al. Lipotoxicity in human pancreatic islets and the protective effect of metformin. Diabetes 2002;51(Suppl 1):S134-7 (Pubitemid 34761508)
-
(2002)
Diabetes
, vol.51
, Issue.SUPPL.
-
-
Lupi, R.1
Del Guerra, S.2
Fierabracci, V.3
Marselli, L.4
Novelli, M.5
Patane, G.6
Boggi, U.7
Mosca, F.8
Piro, S.9
Del Prato, S.10
Marchetti, P.11
-
9
-
-
79960164790
-
Diabetes drug may be associated with increase in risk of bladder cancer
-
Stephenson J. Diabetes drug may be associated with increase in risk of bladder cancer. JAMA 2011;306(2):143
-
(2011)
JAMA
, vol.306
, Issue.2
, pp. 143
-
-
Stephenson, J.1
-
10
-
-
84856896615
-
-
Briefing document: July 13-14 FDA. Washington, DC [Last accessed 1 November 2011]
-
Briefing document: July 13-14, 2010 meeting of the Endocrinologic and Metabolic Drugs Advisory Committee. FDA. Washington, DC, 2010. Available from: www.fda.gov/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/ EndocrinologicandMetabolicDrugs AdvisoryCommittee/ucm191113.htm [Last accessed 1 November 2011]
-
(2010)
2010 Meeting of the Endocrinologic and Metabolic Drugs Advisory Committee
-
-
-
11
-
-
64749100501
-
Medical management of hyperglycemia in type 2 diabetes: A consensus algorithm for the initiation and adjustment of therapy: A consensus statement of the American Diabetes Association and the European Association for the Study of Diabetes
-
Nathan DM, Buse JB, Davidson MB, et al. Medical management of hyperglycemia in type 2 diabetes: a consensus algorithm for the initiation and adjustment of therapy: a consensus statement of the American Diabetes Association and the European Association for the Study of Diabetes. Diabetes Care 2009;32(1):193-203
-
(2009)
Diabetes Care
, vol.32
, Issue.1
, pp. 193-203
-
-
Nathan, D.M.1
Buse, J.B.2
Davidson, M.B.3
-
12
-
-
34248223285
-
Biology of Incretins: GLP-1 and GIP
-
DOI 10.1053/j.gastro.2007.03.054, PII S001650850700580X
-
Baggio LL, Drucker DJ. Biology of incretins: GLP-1 and GIP. Gastroenterology 2007;132:2131-57 (Pubitemid 46711096)
-
(2007)
Gastroenterology
, vol.132
, Issue.6
, pp. 2131-2157
-
-
Baggio, L.L.1
Drucker, D.J.2
-
13
-
-
0035405821
-
Glucagon-Like Peptide-1 and Exendin-4 Stimulate β-Cell Neogenesis in Streptozotocin-Treated Newborn Rats Resulting in Persistently Improved Glucose Homeostasis at Adult Age
-
Tourrel C, Bailbe D, Meile MJ, et al. Glucagon-like peptide-1 and exendin-4 stimulate beta-cell neogenesis in streptozotocin-treated newborn rats resulting in persistently improved glucose homeostasis at adult age. Diabetes 2001;50(7):1562-70 (Pubitemid 33639596)
-
(2001)
Diabetes
, vol.50
, Issue.7
, pp. 1562-1570
-
-
Tourrel, C.1
Bailbe, D.2
Meile, M.-J.3
Kergoat, M.4
Portha, B.5
-
14
-
-
77956581914
-
Incretin agents in type 2 diabetes
-
Ross SA, Ekoe JM. Incretin agents in type 2 diabetes. Can Fam Physician 2010;56(7):639-48
-
(2010)
Can Fam Physician
, vol.56
, Issue.7
, pp. 639-648
-
-
Ross, S.A.1
Ekoe, J.M.2
-
15
-
-
0242710648
-
Seven evolutionarily conserved human rhodopsin G protein-coupled receptors lacking close relatives
-
DOI 10.1016/S0014-5793(03)01196-7
-
Fredriksson R, Hoglund PJ, Gloriam DEI, et al. Seven evolutionarily conserved human rhodopsin G protein-coupled receptors lacking close relatives. FEBS Lett 2003;554:381-8 (Pubitemid 37412518)
-
(2003)
FEBS Letters
, vol.554
, Issue.3
, pp. 381-388
-
-
Fredriksson, R.1
Hoglund, P.J.2
Gloriam, D.E.I.3
Lagerstrom, M.C.4
Schioth, H.B.5
-
19
-
-
78649429773
-
-
WO2004065380
-
Jones RM, Semple G, Fioravanti B, et al. 1,2,3-Trisubstituted aryl and heteroaryl derivatives as modulators of metabolism and the prophylaxis and treatment of disorders related thereto such as diabetes and hyperglycaemia. WO2004065380; 2004
-
(2004)
1, 2,3-Trisubstituted Aryl and Heteroaryl Derivatives As Modulators of Metabolism and the Prophylaxis and Treatment of Disorders Related Thereto Such As Diabetes and Hyperglycaemia
-
-
Jones, R.M.1
Semple, G.2
Fioravanti, B.3
-
20
-
-
0037024360
-
Identification of G protein-coupled receptor genes from the human genome sequence
-
DOI 10.1016/S0014-5793(02)02775-8, PII S0014579302027758
-
Takeda S, Kadowaki S, Haga T, et al. Identification of G protein-coupled receptor genes from the human genome sequence. FEBS Lett 2002;520:97-101 (Pubitemid 34607281)
-
(2002)
FEBS Letters
, vol.520
, Issue.1-3
, pp. 97-101
-
-
Takeda, S.1
Kadowaki, S.2
Haga, T.3
Takaesu, H.4
Mitaku, S.5
-
21
-
-
1842854529
-
G-protein-coupled receptors: New approaches to maximise the impact of GPCRs in drug discovery
-
DOI 10.1517/14728222.8.2.165
-
Davey J. G-protein-coupled receptors: new approaches to maximise the impact of GPCRs in drug discovery. Expert Opin Ther Targets 2004;8:165-70 (Pubitemid 38489541)
-
(2004)
Expert Opinion on Therapeutic Targets
, vol.8
, Issue.2
, pp. 165-170
-
-
Davey, J.1
-
23
-
-
34248527678
-
A role for β-cell-expressed G protein-coupled receptor 119 in glycemic control by enhancing glucose-dependent insulin release
-
DOI 10.1210/en.2006-1608
-
Chu ZL, Jones RM, He H, et al. A role for beta-cell-expressed G protein-coupled receptor 119 in glycemic control by enhancing glucose-dependent insulin release. Endocrinology 2007;148:2601-9. (Pubitemid 46984798)
-
(2007)
Endocrinology
, vol.148
, Issue.6
, pp. 2601-2609
-
-
Chu, Z.-L.1
Jones, R.M.2
He, H.3
Carroll, C.4
Gutierrez, V.5
Lucman, A.6
Moloney, M.7
Gao, H.8
Mondala, H.9
Bagnol, D.10
Unett, D.11
Liang, Y.12
Demarest, K.13
Semple, G.14
Behan, D.P.15
Leonard, J.16
-
24
-
-
33644627958
-
Deorphanization of a G-protein coupled receptor for oleoylethanolamide and its use in the discovery of small molecule hypophagic agents
-
Overton HA, Babbs AJ, Doel SM, et al. Deorphanization of a G-protein coupled receptor for oleoylethanolamide and its use in the discovery of small molecule hypophagic agents. Cell Metab 2006;3:167-75
-
(2006)
Cell Metab
, vol.3
, pp. 167-175
-
-
Overton, H.A.1
Babbs, A.J.2
Doel, S.M.3
-
25
-
-
33750520737
-
Expression and distribution of Gpr119 in the pancreatic islets of mice and rats: Predominant localization in pancreatic polypeptide-secreting PP-cells
-
DOI 10.1016/j.bbrc.2006.10.076, PII S0006291X06023047
-
Sakamoto Y, Inoue H, Kawakami S, et al. Expression and distribution of Gpr119 in the pancreatic islets of mice and rats: predominant localization in pancreatic polypeptide-secreting PP cells. Biochem Biophys Res Commun 2006;351:474-80 (Pubitemid 44666712)
-
(2006)
Biochemical and Biophysical Research Communications
, vol.351
, Issue.2
, pp. 474-480
-
-
Sakamoto, Y.1
Inoue, H.2
Kawakami, S.3
Miyawaki, K.4
Miyamoto, T.5
Mizuta, K.6
Itakura, M.7
-
26
-
-
10644275303
-
Lysophosphatidylcholine enhances glucose-dependent insulin secretion via an orphan G-protein-coupled receptor
-
DOI 10.1016/j.bbrc.2004.11.120, PII S0006291X04027068
-
Soga T, Ohishi T, Matsui T, et al. Lysophosphatidylcholine enhances glucose-dependent insulin secretion via an orphan G-protein coupled receptor. Biochem Biophys Res Commun 2005;326:744-51 (Pubitemid 39655983)
-
(2005)
Biochemical and Biophysical Research Communications
, vol.326
, Issue.4
, pp. 744-751
-
-
Soga, T.1
Ohishi, T.2
Matsui, T.3
Saito, T.4
Matsumoto, M.5
Takasaki, J.6
Matsumoto, S.-I.7
Kamohara, M.8
Hiyama, H.9
Yoshida, S.10
Momose, K.11
Ueda, Y.12
Matsushime, H.13
Kobori, M.14
Furuichi, K.15
-
28
-
-
35748974582
-
Discovery of novel, orally active, synthetic GPR119 agonists as potential agents for treatment of obesity and associated metabolic disorders
-
Fyfe M, Overton H, White J, et al. Discovery of novel, orally active, synthetic GPR119 agonists as potential agents for treatment of obesity and associated metabolic disorders. Diabetes 2006;55(Suppl 1):346
-
(2006)
Diabetes
, vol.55
, Issue.SUPPL. 1
, pp. 346
-
-
Fyfe, M.1
Overton, H.2
White, J.3
-
29
-
-
35748950766
-
GPR119 agonists are potential novel oral agents for the treatment of diabesity
-
Fyfe M, White J, Widdowson P, et al. GPR119 agonists are potential novel oral agents for the treatment of diabesity. Diabetes 2007;56(Suppl 1):532
-
(2007)
Diabetes
, vol.56
, Issue.SUPPL. 1
, pp. 532
-
-
Fyfe, M.1
White, J.2
Widdowson, P.3
-
30
-
-
0028575660
-
Activation of proglucagon gene transcription by protein kinase-A in a novel mouse enterondocrine cell line
-
Drucker DJ, Jin T, Asa SL, et al. Activation of proglucagon gene transcription by protein kinase-A in a novel mouse enterondocrine cell line. Mol Endocrinol 1994;8:1646-55
-
(1994)
Mol Endocrinol
, vol.8
, pp. 1646-1655
-
-
Drucker, D.J.1
Jin, T.2
Asa, S.L.3
-
31
-
-
42449126696
-
A role for intestinal endocrine cell-expressed GPR119 in glycemic control by enhancing GLP-1 and GIP release
-
Chu Z, Carroll C, Alfonso J, et al. A role for intestinal endocrine cell-expressed GPR119 in glycemic control by enhancing GLP-1 and GIP release. Endocrinology 2008;149:2038-47
-
(2008)
Endocrinology
, vol.149
, pp. 2038-2047
-
-
Chu, Z.1
Carroll, C.2
Alfonso, J.3
-
32
-
-
56749170734
-
Endogenous and synthetic agonists of GPR119 differ in signaling pathways and their effects on insulin secretion in MIN6c4 insulinoma cells
-
Ning Y, O'Neill K, Lan H, et al. Endogenous and synthetic agonists of GPR119 differ in signaling pathways and their effects on insulin secretion in MIN6c4 insulinoma cells. Br J Pharmacol 2008;155:1056-65
-
(2008)
Br J Pharmacol
, vol.155
, pp. 1056-1065
-
-
Ning, Y.1
O'Neill, K.2
Lan, H.3
-
33
-
-
77956936188
-
Identification of a novel GPR119 agonist AS1269574 with in vitro and in vivo glucose-stimulated insulin secretion
-
Yoshida S, Ohishi T, Matsui T, et al. Identification of a novel GPR119 agonist, AS1269574, with in vitro and in vivo glucose-stimulated insulin secretion. Biochem Biophys Res Commun 2010;400(3):437-41
-
(2010)
Biochem Biophys Res Commun
, vol.400
, Issue.3
, pp. 437-441
-
-
Yoshida, S.1
Ohishi, T.2
Matsui, T.3
-
34
-
-
78649687741
-
The role of small molecule GPR119 agonist AS1535907 in glucose-stimulated insulin secretion and pancreatic beta-cell function
-
Yoshida S, Ohishi T, Matsui T, et al. The role of small molecule GPR119 agonist, AS1535907, in glucose-stimulated insulin secretion and pancreatic beta-cell function. Diabetes Obes Metab 2011;13(1):34-41
-
(2011)
Diabetes Obes Metab
, vol.13
, Issue.1
, pp. 34-41
-
-
Yoshida, S.1
Ohishi, T.2
Matsui, T.3
-
35
-
-
78149470681
-
Novel GPR119 agonist AS1535907 contributes to first-phase insulin secretion in rat perfused pancreas and diabetic db/db mice
-
Yoshida S, Ohishi T, Matsui T, et al. Novel GPR119 agonist AS1535907 contributes to first-phase insulin secretion in rat perfused pancreas and diabetic db/db mice. Biochem Biophys Res Commun 2010;402(2):280-5
-
(2010)
Biochem Biophys Res Commun
, vol.402
, Issue.2
, pp. 280-285
-
-
Yoshida, S.1
Ohishi, T.2
Matsui, T.3
-
36
-
-
3142728651
-
The role of sulphonylureas in the management of type 2 diabetes mellitus
-
DOI 10.2165/00003495-200464120-00006
-
Rendell M. The role of sulphonylureas in the management of type 2 diabetes mellitus. Drugs 2004;64(12):1339-58 (Pubitemid 38916346)
-
(2004)
Drugs
, vol.64
, Issue.12
, pp. 1339-1358
-
-
Rendell, M.1
-
39
-
-
77957274682
-
AS1907417 a novel GPR119 agonist as an insulinotropic and beta-cell preservative agent for the treatment of type 2 diabetes
-
Yoshida S, Tanaka H, Oshima H, et al. AS1907417, a novel GPR119 agonist, as an insulinotropic and beta-cell preservative agent for the treatment of type 2 diabetes. Biochem Biophys Res Commun 2010;400(4):745-51
-
(2010)
Biochem Biophys Res Commun
, vol.400
, Issue.4
, pp. 745-751
-
-
Yoshida, S.1
Tanaka, H.2
Oshima, H.3
-
40
-
-
0037428479
-
Transcription factor occupancy of the insulin gene in vivo: Evidence for direct regulation by Nkx2.2
-
DOI 10.1074/jbc.M205905200
-
Cissell MA, Zhao L, Sussel L, et al. Transcription factor occupancy of the insulin gene in vivo. Evidence for direct regulation by Nkx 2.2. J Biol Chem 2003;278:751-6 (Pubitemid 36790746)
-
(2003)
Journal of Biological Chemistry
, vol.278
, Issue.2
, pp. 751-756
-
-
Cissell, M.A.1
Zhao, L.2
Sussel, L.3
Henderson, E.4
Stein, R.5
-
41
-
-
14244266611
-
Minireview: Transcriptional regulation in pancreatic development
-
DOI 10.1210/en.2004-1576
-
Habener JF, Kemp DM, Thomas MK. Minireview: transcriptional regulation in pancreatic development. Endocrinology 2005;146(3):1025-34 (Pubitemid 40289291)
-
(2005)
Endocrinology
, vol.146
, Issue.3
, pp. 1025-1034
-
-
Habener, J.F.1
Kemp, D.M.2
Thomas, M.K.3
-
42
-
-
78649522751
-
NKX6.1 promotes PDX-1-induced liver to pancreatic beta-cells reprogramming
-
Gefen-Halevi S, Rachmut IH, Molakandov K, et al. NKX6.1 promotes PDX-1-induced liver to pancreatic beta-cells reprogramming. Cell Reprogram 2010;12(6):655-64
-
(2010)
Cell Reprogram
, vol.12
, Issue.6
, pp. 655-664
-
-
Gefen-Halevi, S.1
Rachmut, I.H.2
Molakandov, K.3
-
43
-
-
0031105975
-
Isolation, characterization, and chromosomal mapping of the human Nkx6.1 gene (NKX6A), a new pancreatic islet homeobox gene
-
DOI 10.1006/geno.1996.4568
-
Inoue H, Rudnick A, German MS, et al. Isolation, characterization, and chromosomal mapping of the human Nkx6.1 gene (NKX6A), a new pancreatic islet homeobox gene. Genomics 1997;40(2):367-70 (Pubitemid 27124103)
-
(1997)
Genomics
, vol.40
, Issue.2
, pp. 367-370
-
-
Inoue, H.1
Rudnick, A.2
German, M.S.3
Veile, R.4
Donis-Keller, H.5
Permutt, M.A.6
-
44
-
-
0034522773
-
Glucagon-like peptide-1 induces cell proliferation and pancreatic-duodenum homeobox-1 expression and increases endocrine cell mass in the pancreas of old, glucose-intolerant rats
-
DOI 10.1210/en.141.12.4600
-
Perfetti R, Zhou J, Doyle ME, et al. Glucagon-like peptide-1 induces cell proliferation and pancreatic-duodenum homeobox-1 expression and increases endocrine cell mass in the pancreas of old, glucose-intolerant rats. Endocrinology 2000;141(12):4600-5 (Pubitemid 32055138)
-
(2000)
Endocrinology
, vol.141
, Issue.12
, pp. 4600-4605
-
-
Perfetti, R.1
Zhou, J.I.E.2
Doyle, M.E.3
Egan, J.M.4
-
45
-
-
33845270456
-
Transcription factors regulating β-cell function
-
DOI 10.1530/eje.1.02277
-
Cerf ME. Transcription factors regulating beta-cell function. Eur J Endocrinol 2006;155:671-9 (Pubitemid 44857490)
-
(2006)
European Journal of Endocrinology
, vol.155
, Issue.5
, pp. 671-679
-
-
Cerf, M.E.1
-
46
-
-
0031985396
-
A newly discovered role of transcription factors involved in pancreas development and the pathogenesis of diabetes mellitus
-
Habener JF, Stoffers DA. A newly discovered role of transcription factors involved in pancreas development and the pathogenesis of diabetes mellitus. Proc Assoc Am Physicians 1998;110(1):12-21 (Pubitemid 28051634)
-
(1998)
Proceedings of the Association of American Physicians
, vol.110
, Issue.1
, pp. 12-21
-
-
Habener, J.F.1
Stoffers, D.A.2
-
47
-
-
77950225021
-
Pancreatic beta cells require NeuroD to achieve and maintain functional maturity
-
Gu C, Stein GH, Pan N, et al. Pancreatic beta cells require NeuroD to achieve and maintain functional maturity. Cell Metab 2010;11(4):298-310
-
(2010)
Cell Metab
, vol.11
, Issue.4
, pp. 298-310
-
-
Gu, C.1
Stein, G.H.2
Pan, N.3
-
48
-
-
70350741391
-
Combination of MafA, PDX-1 and NeuroD is a useful tool to efficiently induce insulin-producing surrogate beta-cells
-
Kaneto H, Matsuoka TA, Katakami N, et al. Combination of MafA, PDX-1 and NeuroD is a useful tool to efficiently induce insulin-producing surrogate beta-cells. Curr Med Chem 2009;16(24):3144-51
-
(2009)
Curr Med Chem
, vol.16
, Issue.24
, pp. 3144-3151
-
-
Kaneto, H.1
Matsuoka, T.A.2
Katakami, N.3
-
49
-
-
0026473236
-
Cellular and molecular biology of the beta cell
-
Steiner DF, James DE. Cellular and molecular biology of the beta cell. Diabetologia 1992;35(Suppl 2):S41-8
-
(1992)
Diabetologia
, vol.35
, Issue.SUPPL. 2
-
-
Steiner, D.F.1
James, D.E.2
-
50
-
-
0030065077
-
Specific co-ordinated regulation of PC3 and PC2 gene expression with that of preproinsulin in insulin-producing βTC3 cells
-
Schuppin GT, Rhodes CJ. Specific co-ordinated regulation of PC3 and PC2 gene expression with that of preproinsulin in insulin-producing beta TC3 cells. Biochem J 1996;313:259-68 (Pubitemid 26013453)
-
(1996)
Biochemical Journal
, vol.313
, Issue.1
, pp. 259-268
-
-
Schuppin, G.T.1
Rhodes, C.J.2
-
51
-
-
42449126696
-
A role for intestinal endocrine cell-expressed G protein-coupled receptor 119 in glycemic control by enhancing glucagon-like peptide-1 and glucose-dependent insulinotropic peptide release
-
DOI 10.1210/en.2007-0966
-
Chu ZL, Carroll C, Alfonso J, et al. A role for intestinal endocrine cell-expressed g protein-coupled receptor 119 in glycemic control by enhancing glucagon-like Peptide-1 and glucose-dependent insulinotropic Peptide release. Endocrinology 2008;149(5):2038-47 (Pubitemid 351574507)
-
(2008)
Endocrinology
, vol.149
, Issue.5
, pp. 2038-2047
-
-
Chu, Z.-L.1
Carroll, C.2
Alfonso, J.3
Gutierrez, V.4
He, H.5
Lucman, A.6
Pedraza, M.7
Mondala, H.8
Gao, H.9
Bagnol, D.10
Chen, R.11
Jones, R.M.12
Behan, D.P.13
Leonard, J.14
-
52
-
-
0030607672
-
Glucagon-like peptide-1-(9-36) amide is a major metabolite of glucagon-like peptide-1-(7-36) amide after in vivo administration to dogs, and it acts as an antagonist on the pancreatic receptor
-
DOI 10.1016/S0014-2999(96)00795-9, PII S0014299996007959
-
Knudsen LB, Pridal L. Glucagon-like peptide-1-(9-36) amide is a major metabolite of glucagon-like peptide-1-(7-36) amide after in vivo administration to dogs, and it acts as an antagonist on the pancreatic receptor. Eur J Pharmacol 1996;318(2-3):429-35 (Pubitemid 27046288)
-
(1996)
European Journal of Pharmacology
, vol.318
, Issue.2-3
, pp. 429-435
-
-
Knudsen, L.B.1
Pridal, L.2
-
53
-
-
0038359686
-
2 on intravenous glucose tolerance and glucose-induced insulin secretion in healthy humans
-
DOI 10.1210/jc.2002-021479
-
Vahl TP, Paty BW, Fuller BD, et al. Effects of GLP-1-(7-36)NH2, GLP-1-(7-37), and GLP-1-(9-36)NH2 on intravenous glucose tolerance and glucose-induced insulin secretion in healthy humans. J Clin Endocrinol Metab 2003;88(4): 1772-9 (Pubitemid 36623403)
-
(2003)
Journal of Clinical Endocrinology and Metabolism
, vol.88
, Issue.4
, pp. 1772-1779
-
-
Vahl, T.P.1
Paty, B.W.2
Fuller, B.D.3
Prigeon, R.L.4
D'Alessio, D.A.5
-
54
-
-
33644627958
-
Deorphanization of a G protein-coupled receptor for oleoylethanolamide and its use in the discovery of small-molecule hypophagic agents
-
Overton HA, Babbs AJ, Doel SM, et al. Deorphanization of a G protein-coupled receptor for oleoylethanolamide and its use in the discovery of small-molecule hypophagic agents. Cell Metab 2006;3(3):167-75
-
(2006)
Cell Metab
, vol.3
, Issue.3
, pp. 167-175
-
-
Overton, H.A.1
Babbs, A.J.2
Doel, S.M.3
-
55
-
-
51849099001
-
Discovery of the first potent and orally efficacious agonist of the orphan G-protein coupled receptor 119
-
Semple G, Fioravanti B, Pereira G, et al. Discovery of the first potent and orally efficacious agonist of the orphan G-protein coupled receptor 119 J Med Chem 2008;51(17): 5172-5
-
(2008)
J Med Chem
, vol.51
, Issue.17
, pp. 5172-5175
-
-
Semple, G.1
Fioravanti, B.2
Pereira, G.3
-
56
-
-
77950062510
-
25-Disubstituted pyridines as potent GPR119 agonists
-
Wu Y, Kuntz JD, Carpenter AJ, et al. 2,5-Disubstituted pyridines as potent GPR119 agonists. Bioorg Med Chem Lett 2010;20(8):2577-81
-
(2010)
Bioorg Med Chem Lett
, vol.20
, Issue.8
, pp. 2577-2581
-
-
Wu, Y.1
Kuntz, J.D.2
Carpenter, A.J.3
-
57
-
-
79955474924
-
Design of potent and selective GPR119 agonists for type II diabetes
-
published online 22 December 2010 doi:10.1016/j.bmcl.2010.12.086
-
Szewczyk JW, Acton J, Adams AD, et al. Design of potent and selective GPR119 agonists for type II diabetes. Bioorg Med Chem Lett 2010;published online 22 December 2010; doi:10.1016/j.bmcl.2010.12.086
-
(2010)
Bioorg Med Chem Lett
-
-
Szewczyk, J.W.1
Acton, J.2
Adams, A.D.3
-
58
-
-
79951726586
-
Design and evaluation of a 2-(2,3,6-trifluorophenyl)acetamide derivative as an agonist of the GPR119 receptor
-
Mascitti V, Stevens BD, Choi C, et al. Design and evaluation of a 2-(2,3,6-trifluorophenyl)acetamide derivative as an agonist of the GPR119 receptor. Bioorg Med Chem Lett 2011;21(5):1306-9
-
(2011)
Bioorg Med Chem Lett
, vol.21
, Issue.5
, pp. 1306-1309
-
-
Mascitti, V.1
Stevens, B.D.2
Choi, C.3
-
59
-
-
84856848690
-
-
American Diabetes Association-71st Meeting; San Diego
-
Nunez DJ, Bush MA, Collins DA, et al. Evaluation of GSK-1292263, a Novel GPR-119 Agonist, in Type 2 Diabetes Mellitus (T2DM): Safety, Tolerability, Pharmacokinetics (PK) and Pharmacodynamics (PD) of Single and Multiple Doses. American Diabetes Association-71st Meeting; San Diego; 2011
-
(2011)
Evaluation of GSK-1292263 A Novel GPR-119 Agonist in Type 2 Diabetes Mellitus (T2DM): Safety Tolerability Pharmacokinetics (PK) and Pharmacodynamics (PD) of Single and Multiple Doses
-
-
Nunez, D.J.1
Bush, M.A.2
Collins, D.A.3
-
60
-
-
84856898231
-
-
Arena Pharmaceuticals Provides Update on GPR119 San Diego [Last accessed 1 November 2011]
-
Arena Pharmaceuticals Provides Update on GPR119 Portfolio for Type 2 Diabetes. PRNewswire. San Diego, 2010. Available from: http://invest.arenapharm. com/releasedetail.cfm?releaseid=527328 [Last accessed 1 November 2011]
-
(2010)
Portfolio for Type 2 Diabetes. PRNewswire
-
-
-
62
-
-
84856824894
-
-
PRNewswire. Paris, 2011 [Last accessed 1 November 2011]
-
Sanofi-aventis: Strong Performance of Growth Platforms in Q1 2011. PRNewswire. Paris, 2011. Available from: http://www.prnewswire.com/news- releases/sanofi-aventis-strong-performance-ofgrowth-platforms-in-q1-2011- 120852319. html [Last accessed 1 November 2011]
-
(2011)
Sanofi-aventis: Strong Performance of Growth Platforms in Q1
-
-
-
63
-
-
70350619609
-
Effects of liraglutide in the treatment of obesity: A randomised, double-blind, placebo-controlled study
-
NN8022-1807 Study Group
-
Astrup A, Rossner S, Van Gaal L, et al. NN8022-1807 Study Group. Effects of liraglutide in the treatment of obesity: a randomised, double-blind, placebo-controlled study. Lancet 2009;374:1606-16
-
(2009)
Lancet
, vol.374
, pp. 1606-1616
-
-
Astrup, A.1
Rossner, S.2
Van Gaal, L.3
-
65
-
-
77955612057
-
Long-term characterization of the diet-induced obese and diet-resistant rat model: A polygenetic rat model mimicking the human obesity syndrome
-
Madsen AN, Hansen G, Paulsen SJ, et al. Long-term characterization of the diet-induced obese and diet-resistant rat model: a polygenetic rat model mimicking the human obesity syndrome. J Endocrinol 2010;206:287-96
-
(2010)
J Endocrinol
, vol.206
, pp. 287-296
-
-
Madsen, A.N.1
Hansen, G.2
Paulsen, S.J.3
-
66
-
-
67649636449
-
Intrameal hepatic portal and intraperitoneal infusions of glucagon-like peptide-1 reduce spontaneous meal size in the rat via different mechanisms
-
Ruttimann EB, Arnold M, Hillebrand JJ, et al. Intrameal hepatic portal and intraperitoneal infusions of glucagon-like peptide-1 reduce spontaneous meal size in the rat via different mechanisms. Endocrinology 2009;150:1174-81
-
(2009)
Endocrinology
, vol.150
, pp. 1174-1181
-
-
Ruttimann, E.B.1
Arnold, M.2
Hillebrand, J.J.3
-
67
-
-
76249104609
-
Liraglutide for weight loss in obese people
-
Thum T, Anker SD. Liraglutide for weight loss in obese people. Lancet 2010;375:551-2
-
(2010)
Lancet
, vol.375
, pp. 551-552
-
-
Thum, T.1
Anker, S.D.2
-
69
-
-
38549162147
-
Exenatide effects on diabetes, obesity, cardiovascular risk factors and hepatic biomarkers in patients with type 2 diabetes treated for at least 3 years
-
DOI 10.1185/030079907X253870
-
Klonoff DC, Buse JB, Nielsen LL, et al. Exenatide effects on diabetes, obesity, cardiovascular risk factors and hepatic biomarkers in patients with type 2 diabetes treated for at least 3 years. Curr Med Res Opin 2008;24(1):275-86 (Pubitemid 351160260)
-
(2008)
Current Medical Research and Opinion
, vol.24
, Issue.1
, pp. 275-286
-
-
Klonoff, D.C.1
Buse, J.B.2
Nielsen, L.L.3
Guan, X.4
Bowlus, C.L.5
Holcombe, J.H.6
Wintle, M.E.7
Maggs, D.G.8
-
70
-
-
0347480400
-
Free fatty acids and type 2 diabetes mellitus
-
Wyne KL. Free fatty acids and type 2 diabetes mellitus. Am J Med 2003;115(Suppl 8A):29S-36S
-
(2003)
Am J Med
, vol.115
, Issue.SUPPL. 8A
-
-
Wyne, K.L.1
-
71
-
-
77749246118
-
Enhanced signaling downstream of ribonucleic Acid-activated protein kinase-like endoplasmic reticulum kinase potentiates lipotoxic endoplasmic reticulum stress in human islets
-
Ladriere L, Igoillo-Esteve M, Cunha DA, et al. Enhanced signaling downstream of ribonucleic Acid-activated protein kinase-like endoplasmic reticulum kinase potentiates lipotoxic endoplasmic reticulum stress in human islets. J Clin Endocrinol Metab 2010;95(3):1442-9
-
(2010)
J Clin Endocrinol Metab
, vol.95
, Issue.3
, pp. 1442-1449
-
-
Ladriere, L.1
Igoillo-Esteve, M.2
Cunha, D.A.3
|